4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-062080
Chief Scientific Officer sold 2,705 shares at an average $28.27 ($76,469)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beskrovnaya Oxana Chief Scientific Officer | 2024-05-16 | Sale 10b5-1 | −2,222 | $28.20 | $62,660 | 150,130 | D |
| Beskrovnaya Oxana Chief Scientific Officer | 2024-05-16 | Sale 10b5-1 | −483 | $28.59 | $13,809 | 149,647 | D |
| Open-market sales · 2,705 sh · avg $28.27 · $76,469 | |||||||
Loading xslF345X05/ownership.xml…